1Saito Y, Yuki H, Kuratani M,et al. A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo[J]. Sci Transl Med, 2013,5 ( 181 ) : 181ra52.
2Pabst C, Krosl J, Fares I, et al. Identification of small molecules that sup-port human leukemia stem cell activity ex vivo[J]. Nat Methods,2014, 11 (4) :436-442.
3Lapidot T,Sirard C, Vormoor J, et al. A cell initiating human acute mye- loid leukaemia after transplantation into SCID mice [J]. Nature, 1994, 367 (6464) : 645-648.
4Pollyea DA, Gutman JA, Gore L, et al. Targeting acute myeloid leukemia stem cells :a review and prineiples for the development of clinical trials[J]. Haematologiea, 2014,99 (8) : 1277-1284.
5Ishikawa F, Yoshida S, Saito Y,et al. Chemotherapy-resistant human AML stem ceils home to and engraft within the bone-marrow endosteal region[J]. Nat Biotechnol, 2007,25 ( 11 ) : 1315-1321.
6Shlush LI,Zandi S, Mitchell A, et al. Identification of pre-leukaemie hae- matopoietie stem ceils in acute leukaemia[J]. Nature, 2014,506 ( 7488 ) : 328-333.
7Majeti R. Monoelonal antibody therapy directed against human aeute mye- loid leukemia stem cells[J[. Oneogene, 2011,30 (9) : 1009-1019.
2Lübbert M,Suciu S,Baila L,et al.Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-riskmyelodysplastic syndrome(MDS)ineligible for intensive chemotherapy:final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDSStudy Group[J].J Clin Oncol,2011,29(15):1987-1996.
3Nishino M,Jackman DM,Hatabu H,et al.New response evaluation criteria in solid tumors(RECIST)guidelines for advanced non-small cell lung cancer:comparison with original RECIST and impact on assessment of tumor response to targeted therapy[J].AJR Am J Roentgenol,2010,195(3):221-228.
4Dinner SN,Giles FJ,Altman JK.New strategies for relapsed acute myeloid leukemia:fertile ground for translational research[J].Curr Opin Hematol,2014,21(2):79-86.
5Ritchie EK,Feldman EJ,Christos PJ,et al.Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia[J].Leuk Lymphoma,2013,54(9):2003-2007.
6Wang LX,Mei ZY,Zhou JH,et al.Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses[J].PloS One,2013,8(5):62924.
7Cashen AF,Schiller GJ,O′Donnell MR,et al.Municenter,phaseⅡstudy of decitabine for the first-line treatment of older patients with acute myeloid leukemia[J].J Clin Oncol,2010,28(4):556-561.
